Clearside Biomedical Inc.(CLSD)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

CLSD Clearside Biomedical Inc.

盘后交易 09-18 17:07:29 EDT

1.30

+0.00

-0.38%

盘后1.30

+0.000.00%

16:00 EDT

最高1.35	最低1.29	成交量24.24万
今开1.30	昨收1.31	日振幅4.60%
总市值9,717万	流通市值8,989万	总股本7,475万
成交额32.05万	换手率0.35%	流通股本6,914万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"CLSD","market":"US","secType":"STK","nameCN":"Clearside Biomedical Inc.","latestPrice":1.3,"timestamp":1726689600000,"preClose":1.305,"halted":0,"volume":242446,"hourTrading":{"tag":"盘后","latestPrice":1.3,"preClose":1.3,"latestTime":"16:00 EDT","volume":819,"amount":1064.7,"timestamp":1726689602608},"delay":0,"floatShares":69143167,"shares":74745572,"eps":-0.501568,"marketStatus":"盘后交易","marketStatusCode":4,"change":-0.005,"latestTime":"09-18 17:07:29 EDT","open":1.3,"high":1.35,"low":1.29,"amount":320535.456385,"amplitude":0.045977,"askPrice":1.35,"askSize":804,"bidPrice":1.29,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-0.501568,"exchange":"NASDAQ","tradingStatus":3,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1726704000000},"adr":0,"listingDate":1464840000000,"adjPreClose":1.305,"adrRate":0,"preHourTrading":{"tag":"盘前","latestPrice":1.34,"preClose":1.305,"latestTime":"09:07 EDT","volume":510,"amount":698.4000179999999,"timestamp":1726664830974},"postHourTrading":{"tag":"盘后","latestPrice":1.3,"preClose":1.3,"latestTime":"16:00 EDT","volume":819,"amount":1064.7,"timestamp":1726689602608},"volumeRatio":0.417108,"impliedVol":1.6304,"impliedVolPercentile":0.4762},"requestUrl":"/m/hq/s/CLSD?invite=TIGER025","defaultTab":"news","newsList":[{"id":"2460717442","title":"Clearside Biomedical, Inc.2024财年第二财季实现净利润-7.59百万美元，同比增加16.68%","url":"https://stock-news.laohu8.com/highlight/detail?id=2460717442","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2460717442?lang=zh_cn&edition=full","pubTime":"2024-08-19 00:02","pubTimestamp":1723996941,"startTime":"0","endTime":"0","summary":"8月19日，Clearside Biomedical, Inc.公布财报，公告显示公司2024财年第二财季净利润为-7.59百万美元，同比增加16.68%；其中营业收入为90000.00美元，同比减少91.18%，每股基本收益为-0.10美元。机构评级：截至2024年8月19日，当前有6家机构对Clearside Biomedical, Inc.目标价做出预测，其中目标均价为5.50美元，其中最低目标价为4.00美元，最高目标价为8.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024081900023095a3851a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024081900023095a3851a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CLSD"],"gpt_icon":0},{"id":"2460223406","title":"Clearside Biomedical, Inc.盘中异动 下午盘大幅下跌7.58%","url":"https://stock-news.laohu8.com/highlight/detail?id=2460223406","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2460223406?lang=zh_cn&edition=full","pubTime":"2024-08-17 02:46","pubTimestamp":1723833970,"startTime":"0","endTime":"0","summary":"北京时间2024年08月17日02时46分，Clearside Biomedical, Inc.股票出现波动，股价大幅下跌7.58%。Clearside Biomedical, Inc.股票所在的生物技术行业中，整体涨幅为0.14%。其相关个股中，Cingulate Inc C/Wts 10/12/2026 、Cingulate Inc.、Geovax Labs, Inc.涨幅较大，Cingulate Inc.、Seelos Therapeutics, Inc.、Geovax Labs, Inc.较为活跃，换手率分别为10529.89%、2080.93%、1764.65%，振幅较大的相关个股有Cingulate Inc C/Wts 10/12/2026 、Cingulate Inc.、Geovax Labs, Inc.，振幅分别为523.81%、252.50%、144.78%。Clearside Biomedical, Inc.公司简介：Clearside Biomedical Inc 是一家总部位于美国的临床生物制药公司，致力于开发通过脉络膜上腔或 SCS 治疗眼部致盲疾病的药物疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240817024610a1d4b1d2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240817024610a1d4b1d2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","CLSD","CING"],"gpt_icon":1},{"id":"2459996739","title":"Clearside Biomedical Inc 报告截至 6 月的季度业绩 - 收益摘要","url":"https://stock-news.laohu8.com/highlight/detail?id=2459996739","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459996739?lang=zh_cn&edition=full","pubTime":"2024-08-13 09:33","pubTimestamp":1723512819,"startTime":"0","endTime":"0","summary":"   * Clearside Biomedical Inc   报告了截至6月底的季度调整后每股亏损10美分，高于去年同期的每股-15美分。六位分析师对该季度的平均预期是每股亏损 13 美分。华尔街预期为每股-16美分至-12美分。* Clearside Biomedical Inc公布的本季度每股收益为亏损10美分。* Clearside Biomedical Inc的股价本季度下跌了16.2%，今年迄今为止下跌了6.8%。8月13日 - 预测变化   * 过去三个月，分析师的平均盈利预期下降了约 0.7%。华尔街对 Clearside Biomedical Inc 的 12 个月目标价中位数为 5.00 美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Clearside Biomedical Inc 报告截至 6 月的季度业绩 - 收益摘要","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CLSD","BK4007"],"gpt_icon":0},{"id":"2458526959","title":"Clearside Biomedical Inc   预计每股亏损13美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2458526959","media":"Reuters","labels":["preview"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2458526959?lang=zh_cn&edition=full","pubTime":"2024-08-10 08:03","pubTimestamp":1723248195,"startTime":"0","endTime":"0","summary":"   * Clearside Biomedical Inc    将于8月12日公布截至2024年6月30日的财报，预计该公司的季度收入将出现下降。* 根据LSEG的数据，5位分析师的平均预期显示，这家总部位于佐治亚州Alpharetta的公司的营收将从去年同期的102万美元降至15.2万美元，降幅为85.1%。* LSEG 分析师对 Clearside Biomedical Inc 的平均预期是每股亏损 13 美分。* 华尔街对 Clearside Biomedical Inc 的 12 个月目标价中位数为 5.00 美元，高于上一次收盘价 1.09 美元。8月10日 - 上一季度业绩。除非另有说明，所有数据均以美元为单位。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Clearside Biomedical Inc   预计每股亏损13美分 - 财报前瞻","news_tag":"preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CLSD"],"gpt_icon":0},{"id":"2457124983","title":"Clearside Biomedical, Inc.盘中异动 早盘股价大跌5.53%报0.973美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2457124983","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457124983?lang=zh_cn&edition=full","pubTime":"2024-08-08 22:13","pubTimestamp":1723126434,"startTime":"0","endTime":"0","summary":"北京时间2024年08月08日22时13分，Clearside Biomedical, Inc.股票出现异动，股价急速下跌5.53%。截至发稿，该股报0.973美元/股，成交量5.1002万股，换手率0.07%，振幅3.88%。Clearside Biomedical, Inc.股票所在的生物技术行业中，整体涨幅为2.10%。Clearside Biomedical, Inc.公司简介：Clearside Biomedical Inc 是一家总部位于美国的临床生物制药公司，致力于开发通过脉络膜上腔或 SCS 治疗眼部致盲疾病的药物疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240808221354af96a03e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240808221354af96a03e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CLSD","BK4007"],"gpt_icon":0},{"id":"2457847228","title":"Clearside Biomedical, Inc.盘中异动 股价大跌5.50%报1.03美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2457847228","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457847228?lang=zh_cn&edition=full","pubTime":"2024-08-07 22:29","pubTimestamp":1723040970,"startTime":"0","endTime":"0","summary":"北京时间2024年08月07日22时29分，Clearside Biomedical, Inc.股票出现波动，股价大幅下跌5.50%。截至发稿，该股报1.03美元/股，成交量6.8791万股，换手率0.09%，振幅6.54%。Clearside Biomedical, Inc.股票所在的生物技术行业中，整体跌幅为1.84%。Clearside Biomedical, Inc.公司简介：Clearside Biomedical Inc 是一家总部位于美国的临床生物制药公司，致力于开发通过脉络膜上腔或 SCS 治疗眼部致盲疾病的药物疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024080722293196824cee&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024080722293196824cee&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","CLSD"],"gpt_icon":0},{"id":"2452436720","title":"Clearside Biomedical, Inc.盘中异动 股价大跌5.79%报1.14美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2452436720","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2452436720?lang=zh_cn&edition=full","pubTime":"2024-07-18 23:44","pubTimestamp":1721317479,"startTime":"0","endTime":"0","summary":"北京时间2024年07月18日23时44分，Clearside Biomedical, Inc.股票出现波动，股价急速下挫5.79%。Clearside Biomedical, Inc.股票所在的生物技术行业中，整体跌幅为1.88%。其相关个股中，Onconetix, Inc.、Silo Pharma, Inc.、Lixte Biotechnology Holdings  Inc C/Wts 30/11/2025 涨幅较大，Silo Pharma, Inc.、Salarius Pharmaceuticals, Inc.、Onconetix, Inc.较为活跃，换手率分别为2217.20%、1939.92%、1169.32%，振幅较大的相关个股有Silo Pharma, Inc.、Salarius Pharmaceuticals, Inc.、Onconetix, Inc.，振幅分别为93.33%、91.50%、86.24%。Clearside Biomedical, Inc.公司简介：Clearside Biomedical Inc 是一家总部位于美国的临床生物制药公司，致力于开发通过脉络膜上腔或 SCS 治疗眼部致盲疾病的药物疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240718234440af930069&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240718234440af930069&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","CLSD"],"gpt_icon":0},{"id":"2448946667","title":"Clearside Biomedical, Inc.盘中异动 下午盘股价大跌5.38%","url":"https://stock-news.laohu8.com/highlight/detail?id=2448946667","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2448946667?lang=zh_cn&edition=full","pubTime":"2024-07-02 02:04","pubTimestamp":1719857095,"startTime":"0","endTime":"0","summary":"北京时间2024年07月02日02时04分，Clearside Biomedical, Inc.股票出现波动，股价快速下跌5.38%。Clearside Biomedical, Inc.股票所在的生物技术行业中，整体涨幅为0.52%。Clearside Biomedical, Inc.公司简介：Clearside Biomedical Inc 是一家总部位于美国的临床生物制药公司，致力于开发通过脉络膜上腔或 SCS 治疗眼部致盲疾病的药物疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240702020455968187a6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240702020455968187a6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CLSD","BK4007"],"gpt_icon":0},{"id":"2446567032","title":"Clearside Biomedical, Inc.盘中异动 大幅拉升5.55%报1.28美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2446567032","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2446567032?lang=zh_cn&edition=full","pubTime":"2024-06-28 03:54","pubTimestamp":1719518061,"startTime":"0","endTime":"0","summary":"北京时间2024年06月28日03时54分，Clearside Biomedical, Inc.股票出现异动，股价快速拉升5.55%。Clearside Biomedical, Inc.股票所在的生物技术行业中，整体跌幅为0.51%。Clearside Biomedical, Inc.公司简介：Clearside Biomedical Inc 是一家总部位于美国的临床生物制药公司，致力于开发通过脉络膜上腔或 SCS 治疗眼部致盲疾病的药物疗法。消息层面，截至03时54分，《韦德布什维持Clearside Biomedical买入评级，上调目标价至5美元》资讯为影响Clearside Biomedical, Inc.的重要信息。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240628035421af8f8e4c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240628035421af8f8e4c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","CLSD"],"gpt_icon":0},{"id":"2446316260","title":"Clearside Biomedical, Inc.盘中异动 股价大跌6.40%","url":"https://stock-news.laohu8.com/highlight/detail?id=2446316260","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2446316260?lang=zh_cn&edition=full","pubTime":"2024-06-27 00:51","pubTimestamp":1719420696,"startTime":"0","endTime":"0","summary":"北京时间2024年06月27日00时51分，Clearside Biomedical, Inc.股票出现异动，股价快速下跌6.40%。Clearside Biomedical, Inc.股票所在的生物技术行业中，整体跌幅为0.96%。Clearside Biomedical, Inc.公司简介：Clearside Biomedical Inc 是一家总部位于美国的临床生物制药公司，致力于开发通过脉络膜上腔或 SCS 治疗眼部致盲疾病的药物疗法。消息层面，截至00时51分，《韦德布什维持Clearside Biomedical买入评级，上调目标价至5美元》资讯为影响Clearside Biomedical, Inc.的重要信息。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240627005136aef6c25b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240627005136aef6c25b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","CLSD"],"gpt_icon":0},{"id":"2446846066","title":"Clearside Biomedical, Inc.盘中异动 早盘股价大涨9.25%","url":"https://stock-news.laohu8.com/highlight/detail?id=2446846066","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2446846066?lang=zh_cn&edition=full","pubTime":"2024-06-25 21:31","pubTimestamp":1719322281,"startTime":"0","endTime":"0","summary":"北京时间2024年06月25日21时31分，Clearside Biomedical, Inc.股票出现异动，股价大幅拉升9.25%。Clearside Biomedical, Inc.股票所在的生物技术行业中，整体涨幅为0.64%。Clearside Biomedical, Inc.公司简介：Clearside Biomedical Inc 是一家总部位于美国的临床生物制药公司，致力于开发通过脉络膜上腔或 SCS 治疗眼部致盲疾病的药物疗法。消息层面，截至21时31分，《韦德布什维持Clearside Biomedical买入评级，上调目标价至5美元》资讯为影响Clearside Biomedical, Inc.的重要信息。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024062521312195d6a7b3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024062521312195d6a7b3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CLSD","BK4007"],"gpt_icon":0},{"id":"2446589092","title":"Clearside Biomedical(CLSD.US)获奥本海默首次覆盖，给予优于大市评级, 目标价5.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2446589092","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2446589092?lang=zh_cn&edition=full","pubTime":"2024-06-25 17:43","pubTimestamp":1719308621,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK4007","CLSD"],"gpt_icon":0},{"id":"2445434072","title":"Clearside Biomedical, Inc.盘中异动 早盘大幅跳水6.39%","url":"https://stock-news.laohu8.com/highlight/detail?id=2445434072","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2445434072?lang=zh_cn&edition=full","pubTime":"2024-06-24 21:34","pubTimestamp":1719236098,"startTime":"0","endTime":"0","summary":"北京时间2024年06月24日21时34分，Clearside Biomedical, Inc.股票出现波动，股价快速下挫6.39%。Clearside Biomedical, Inc.股票所在的生物技术行业中，整体涨幅为0.70%。Clearside Biomedical, Inc.公司简介：Clearside Biomedical Inc 是一家总部位于美国的临床生物制药公司，致力于开发通过脉络膜上腔或 SCS 治疗眼部致盲疾病的药物疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240624213459af8eeb83&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240624213459af8eeb83&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CLSD","BK4007"],"gpt_icon":0},{"id":"2444506404","title":"Clearside Biomedical, Inc.盘中异动 临近收盘股价大跌5.08%报1.12美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2444506404","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2444506404?lang=zh_cn&edition=full","pubTime":"2024-06-19 03:36","pubTimestamp":1718739409,"startTime":"0","endTime":"0","summary":"北京时间2024年06月19日03时36分，Clearside Biomedical, Inc.股票出现异动，股价急速下挫5.08%。Clearside Biomedical, Inc.股票所在的生物技术行业中，整体跌幅为0.69%。Clearside Biomedical, Inc.公司简介：Clearside Biomedical Inc 是一家总部位于美国的临床生物制药公司，致力于开发通过脉络膜上腔或 SCS 治疗眼部致盲疾病的药物疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240619033649941ef483&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240619033649941ef483&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CLSD","BK4007"],"gpt_icon":0},{"id":"2442459263","title":"Clearside Biomedical, Inc.盘中异动 下午盘快速上涨5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2442459263","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2442459263?lang=zh_cn&edition=full","pubTime":"2024-06-12 03:23","pubTimestamp":1718133799,"startTime":"0","endTime":"0","summary":"北京时间2024年06月12日03时23分，Clearside Biomedical, Inc.股票出现波动，股价大幅拉升5.00%。Clearside Biomedical, Inc.股票所在的生物技术行业中，整体跌幅为0.39%。Clearside Biomedical, Inc.公司简介：Clearside Biomedical Inc 是一家总部位于美国的临床生物制药公司，致力于开发通过脉络膜上腔或 SCS 治疗眼部致盲疾病的药物疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240612032319aef45fc8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240612032319aef45fc8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CLSD","BK4007"],"gpt_icon":0},{"id":"2441018351","title":"Clearside Biomedical, Inc.盘中异动 下午盘股价大涨5.04%报1.25美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2441018351","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2441018351?lang=zh_cn&edition=full","pubTime":"2024-06-08 03:29","pubTimestamp":1717788590,"startTime":"0","endTime":"0","summary":"北京时间2024年06月08日03时29分，Clearside Biomedical, Inc.股票出现波动，股价急速上涨5.04%。Clearside Biomedical, Inc.股票所在的生物技术行业中，整体跌幅为0.33%。Clearside Biomedical, Inc.公司简介：Clearside Biomedical Inc 是一家总部位于美国的临床生物制药公司，致力于开发通过脉络膜上腔或 SCS 治疗眼部致盲疾病的药物疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024060803295196812fd1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024060803295196812fd1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","CLSD"],"gpt_icon":0},{"id":"2440491792","title":"Clearside Biomedical, Inc.盘中异动 股价大跌5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2440491792","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2440491792?lang=zh_cn&edition=full","pubTime":"2024-06-03 22:52","pubTimestamp":1717426361,"startTime":"0","endTime":"0","summary":"北京时间2024年06月03日22时52分，Clearside Biomedical, Inc.股票出现异动，股价急速下挫5.00%。Clearside Biomedical, Inc.股票所在的生物技术行业中，整体涨幅为1.30%。Clearside Biomedical, Inc.公司简介：Clearside Biomedical Inc 是一家总部位于美国的临床生物制药公司，致力于开发通过脉络膜上腔或 SCS 治疗眼部致盲疾病的药物疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240603225241aef31d2f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240603225241aef31d2f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CLSD","BK4007"],"gpt_icon":0},{"id":"2439620446","title":"Clearside Biomedical, Inc.盘中异动 股价大涨6.67%报1.44美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2439620446","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2439620446?lang=zh_cn&edition=full","pubTime":"2024-05-31 00:55","pubTimestamp":1717088135,"startTime":"0","endTime":"0","summary":"北京时间2024年05月31日00时55分，Clearside Biomedical, Inc.股票出现波动，股价快速上涨6.67%。Clearside Biomedical, Inc.股票所在的生物技术行业中，整体涨幅为0.21%。Clearside Biomedical, Inc.公司简介：Clearside Biomedical Inc 是一家总部位于美国的临床生物制药公司，致力于开发通过脉络膜上腔或 SCS 治疗眼部致盲疾病的药物疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240531005535af8b2d35&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240531005535af8b2d35&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","CLSD"],"gpt_icon":0},{"id":"2438370435","title":"Clearside Biomedical, Inc.盘中异动 大幅上涨5.19%报1.42美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2438370435","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2438370435?lang=zh_cn&edition=full","pubTime":"2024-05-28 21:59","pubTimestamp":1716904775,"startTime":"0","endTime":"0","summary":"北京时间2024年05月28日21时59分，Clearside Biomedical, Inc.股票出现异动，股价大幅上涨5.19%。Clearside Biomedical, Inc.股票所在的生物技术行业中，整体跌幅为1.71%。其相关个股中，Insmed Incorporated、Calliditas Therapeutics Ab、Conduit Pharmaceuticals Inc C/Wts 22/09/2028涨幅较大，Exicure, Inc.、Mustang Bio, Inc.、Jaguar Health, Inc.较为活跃，换手率分别为49.58%、12.97%、11.29%，振幅较大的相关个股有Exicure, Inc.、G1 Therapeutics, Inc.、Reviva Pharmaceuticals Holdings Inc C/Wts 25/12/2025，振幅分别为70.52%、21.76%、20.73%。Clearside Biomedical, Inc.公司简介：Clearside Biomedical Inc 是一家总部位于美国的临床生物制药公司，致力于开发通过脉络膜上腔或 SCS 治疗眼部致盲疾病的药物疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240528215936aef21b82&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240528215936aef21b82&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CLSD","BK4007"],"gpt_icon":0},{"id":"2437811299","title":"Clearside Biomedical, Inc.盘中异动 早盘股价大跌5.02%报1.42美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2437811299","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2437811299?lang=zh_cn&edition=full","pubTime":"2024-05-22 22:10","pubTimestamp":1716387029,"startTime":"0","endTime":"0","summary":"北京时间2024年05月22日22时10分，Clearside Biomedical, Inc.股票出现异动，股价快速下跌5.02%。截至发稿，该股报1.42美元/股，成交量27.9779万股，换手率0.37%，振幅6.04%。Clearside Biomedical, Inc.股票所在的生物技术行业中，整体涨幅为0.08%。Clearside Biomedical, Inc.公司简介：Clearside Biomedical Inc 是一家总部位于美国的临床生物制药公司，致力于开发通过脉络膜上腔或 SCS 治疗眼部致盲疾病的药物疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240522221029af89af46&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240522221029af89af46&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CLSD","BK4007"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.clearsidebio.com","stockEarnings":[{"period":"1week","weight":0.1549},{"period":"1month","weight":0.2921},{"period":"3month","weight":0.1652},{"period":"6month","weight":-0.275},{"period":"1year","weight":0.5371},{"period":"ytd","weight":0.1154}],"compareEarnings":[{"period":"1week","weight":0.026},{"period":"1month","weight":0.0158},{"period":"3month","weight":0.0266},{"period":"6month","weight":0.0783},{"period":"1year","weight":0.2692},{"period":"ytd","weight":0.1846}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Clearside Biomedical, Inc.是一个后期临床生物制药公司，开发先入类药物疗法来治疗眼睛的致盲疾病。公司目前的候选产品着力解决影响视网膜和脉络膜，尤其是黄斑水肿相关的疾病，并注入到使用其专有的SCS微量注射器脉络膜上腔。公司于2011年5月26日在特拉华州注册成立。","yearOnYearQuotes":[{"month":1,"riseRate":0.625,"avgChangeRate":0.04293},{"month":2,"riseRate":0.5,"avgChangeRate":-0.031824},{"month":3,"riseRate":0.5,"avgChangeRate":0.06208},{"month":4,"riseRate":0.5,"avgChangeRate":-0.011671},{"month":5,"riseRate":0.25,"avgChangeRate":-0.080267},{"month":6,"riseRate":0.75,"avgChangeRate":0.163204},{"month":7,"riseRate":0.444444,"avgChangeRate":-0.038074},{"month":8,"riseRate":0.333333,"avgChangeRate":-0.074112},{"month":9,"riseRate":0.444444,"avgChangeRate":0.153858},{"month":10,"riseRate":0.375,"avgChangeRate":0.071384},{"month":11,"riseRate":0.5,"avgChangeRate":-0.036595},{"month":12,"riseRate":0.375,"avgChangeRate":0.066515}],"exchange":"NASDAQ","name":"Clearside Biomedical Inc.","nameEN":"Clearside Biomedical"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.26.4","shortVersion":"4.26.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Clearside Biomedical Inc.(CLSD)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Clearside Biomedical Inc.(CLSD)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Clearside Biomedical Inc.,CLSD,Clearside Biomedical Inc.股票,Clearside Biomedical Inc.股票老虎,Clearside Biomedical Inc.股票老虎国际,Clearside Biomedical Inc.行情,Clearside Biomedical Inc.股票行情,Clearside Biomedical Inc.股价,Clearside Biomedical Inc.股市,Clearside Biomedical Inc.股票价格,Clearside Biomedical Inc.股票交易,Clearside Biomedical Inc.股票购买,Clearside Biomedical Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Clearside Biomedical Inc.(CLSD)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Clearside Biomedical Inc.(CLSD)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}